Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 2687605, 6 pages
http://dx.doi.org/10.1155/2016/2687605
Clinical Study

Fecal Microbiota Transplantation Using Upper Gastrointestinal Tract for the Treatment of Refractory or Severe Complicated Clostridium difficile Infection in Elderly Patients in Poor Medical Condition: The First Study in an Asian Country

1Division of Gastroenterology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seocho-gu, Seoul 137-070, Republic of Korea
2Division of Infectious Diseases, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpodaero, Seocho-gu, Seoul 137-070, Republic of Korea

Received 22 October 2015; Revised 28 December 2015; Accepted 3 January 2016

Academic Editor: Jinsheng Yu

Copyright © 2016 Tae-Geun Gweon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Freeman, M. P. Bauer, S. D. Baines et al., “The changing epidemiology of Clostridium difficile infections,” Clinical Microbiology Reviews, vol. 23, no. 3, pp. 529–549, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. B. A. Miller, L. F. Chen, D. J. Sexton, and D. J. Anderson, “Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals,” Infection Control and Hospital Epidemiology, vol. 32, no. 4, pp. 387–390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Hamilton, A. R. Weingarden, M. J. Sadowsky, and A. Khoruts, “Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection,” The American Journal of Gastroenterology, vol. 107, no. 5, pp. 761–767, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. L. J. Brandt, O. C. Aroniadis, M. Mellow et al., “Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection,” American Journal of Gastroenterology, vol. 107, no. 7, pp. 1079–1087, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. E. van Nood, A. Vrieze, M. Nieuwdorp et al., “Duodenal infusion of donor feces for recurrent Clostridium difficile,” The New England Journal of Medicine, vol. 368, no. 5, pp. 407–415, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Gough, H. Shaikh, and A. R. Manges, “Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent clostridium difficile infection,” Clinical Infectious Diseases, vol. 53, no. 10, pp. 994–1002, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. C. R. Kelly, L. de Leon, and N. Jasutkar, “Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results,” Journal of Clinical Gastroenterology, vol. 46, no. 2, pp. 145–149, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Lo Vecchio and G. M. Zacur, “Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options,” Current Opinion in Gastroenterology, vol. 28, no. 1, pp. 1–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Y. Hu, K. Katchar, L. Kyne et al., “Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection,” Gastroenterology, vol. 136, no. 4, pp. 1206–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. D. A. Karnofsky, W. H. Abelmann, L. F. Craver, and J. H. Burchenal, “The use of the nitrogen mustards in the palliative treatment of carcinoma—with particular reference to bronchogenic carcinoma,” Cancer, vol. 1, no. 4, pp. 634–656, 1948. View at Publisher · View at Google Scholar
  11. M. E. Charlson, P. Pompei, K. L. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Publisher · View at Google Scholar · View at Scopus
  12. S. H. Cohen, D. N. Gerding, S. Johnson et al., “Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA),” Infection Control and Hospital Epidemiology, vol. 31, no. 5, pp. 431–455, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. R. Jaber, S. Olafsson, W. L. Fung, and M. E. Reeves, “Clinical review of the management of fulminant Clostridium difficile infection,” American Journal of Gastroenterology, vol. 103, no. 12, pp. 3195–3203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. T.-G. Gweon, K. J. Lee, D. Kang et al., “A case of toxic megacolon caused by Clostridium difficile infection and treated with fecal microbiota transplantation,” Gut and Liver, vol. 9, no. 2, pp. 247–250, 2015. View at Publisher · View at Google Scholar
  15. C. R. Kelly, C. Ihunnah, M. Fischer et al., “Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients,” The American Journal of Gastroenterology, vol. 109, no. 7, pp. 1065–1071, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Neemann, D. D. D. Eichele, P. P. W. Smith, R. Bociek, M. Akhtari, and A. Freifeld, “Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient,” Transplant Infectious Disease, vol. 14, no. 6, pp. E161–E165, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Zainah, M. Hassan, L. Shiekh-Sroujieh, S. Hassan, G. Alangaden, and M. Ramesh, “Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection,” Digestive Diseases and Sciences, vol. 60, no. 1, pp. 181–185, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. T. G. Gweon, M. G. Choi, S. K. Lee et al., “Two cases of refractory pseudomembranous colitis that healed following fecal microbiota transplantation,” Korean Journal of Medicine, vol. 84, no. 3, pp. 395–399, 2013. View at Publisher · View at Google Scholar
  19. J. E. Kim, T.-G. Gweon, C. D. Yeo et al., “A case of Clostridium difficile infection complicated by acute respiratory distress syndrome treated with fecal microbiota transplantation,” World Journal of Gastroenterology, vol. 20, no. 35, pp. 12687–12690, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. T.-G. Gweon, M.-G. Choi, M. K. Baeg et al., “Hematologic diseases: high risk of Clostridium difficile associated diarrhea,” World Journal of Gastroenterology, vol. 20, no. 21, pp. 6602–6607, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Kim, J. O. Kang, H. Kim et al., “Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea,” Clinical Microbiology and Infection, vol. 19, no. 6, pp. 521–527, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. V. G. Loo, A.-M. Bourgault, L. Poirier et al., “Host and pathogen factors for Clostridium difficile infection and colonization,” The New England Journal of Medicine, vol. 365, no. 18, pp. 1693–1703, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. P. K. Kutty, C. W. Woods, A. C. Sena et al., “Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA,” Emerging Infectious Diseases, vol. 16, no. 2, pp. 197–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. O. Karlström, B. Fryklund, K. Tullus, and L. G. Burman, “A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden,” Clinical Infectious Diseases, vol. 26, no. 1, pp. 141–145, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Gupta and S. Khanna, “Community-acquired Clostridium difficile infection: an increasing public health threat,” Infection and Drug Resistance, vol. 7, pp. 63–72, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. A. S. Chitnis, S. M. Holzbauer, R. M. Belflower et al., “Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011,” JAMA Internal Medicine, vol. 173, no. 14, pp. 1359–1367, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Mattila, R. Uusitalo-Seppälä, M. Wuorela et al., “Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection,” Gastroenterology, vol. 142, no. 3, pp. 490–496, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. K. W. Garey, S. Sethi, Y. Yadav, and H. L. DuPont, “Meta-analysis to assess risk factors for recurrent Clostridium difficile infection,” Journal of Hospital Infection, vol. 70, no. 4, pp. 298–304, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Y. Hu, K. Katchar, L. Kyne et al., “Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection,” Gastroenterology, vol. 136, no. 4, pp. 1206–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus